Domain 10 of 12·PRIORITY-ELIGIBLE

Drug Therapies & Medication

Medication regime complexity, administration risks, and monitoring requirements.

New to CHC? Run the free 60-second screener first →

What this domain measures

The Drug Therapies and Medication: Symptom Control domain captures the complexity of a person's medication regime — including injections, controlled drugs, syringe drivers, IV medication, complex titration, covert administration, and the monitoring required to administer those medicines safely. It is one of four Priority-eligible domains: a single Priority score here can secure CHC eligibility on this domain alone, typically in end-of-life or syringe-driver scenarios.

How it's scored (Annex C wording)

DST scoring levels for the Drug Therapies & Medication domain, with verbatim Annex C descriptors.
Level	DST descriptor
No needs	Symptoms are managed effectively and without any problems, and medication is not resulting in any unmanageable side-effects.
Low	Requires supervision/administration of and/or prompting with medication but shows compliance with medication regime. OR Mild pain that is predictable and/or is associated with certain activities of daily living. Pain and other symptoms do not have an impact on the provision of care.
Moderate	Requires the administration of medication (by a registered nurse, carer or care worker) due to: • non-compliance, or type of medication (for example insulin), or • route of medication (for example PEG). OR Moderate pain which follows a predictable pattern; or other symptoms which are having a moderate effect on other domains or on the provision of care.
High	Requires administration and monitoring of medication regime by a registered nurse, carer or care worker specifically trained for the task because there are risks associated with the potential fluctuation of the medical condition or mental state, or risks regarding the effectiveness of the medication or the potential nature or severity of side-effects. However, with such monitoring the condition is usually non-problematic to manage. OR Moderate pain or other symptoms which is/are having a significant effect on other domains or on the provision of care.
Severe	Requires administration and monitoring of medication regime by a registered nurse, carer or care worker specifically trained for this task because there are risks associated with the potential fluctuation of the medical condition or mental state, or risks regarding the effectiveness of the medication or the potential nature or severity of side-effects. Even with such monitoring the condition is usually problematic to manage. OR Severe recurrent or constant pain which is not responding to treatment. OR Non-compliance with medication, placing them at severe risk of relapse.
Priority	Has a drug regime that requires daily monitoring by a registered nurse to ensure effective symptom and pain management associated with a rapidly changing and/or deteriorating condition. OR Unremitting and overwhelming pain despite all efforts to control pain effectively.

Evidence that moves the score up

Medication Administration Records (MAR) covering the last 12 weeks, including PRN administration
Prescription showing regime complexity — number of medicines, controlled drugs, syringe driver components
Specialist nurse involvement records (palliative care, district nurse, clinical nurse specialist)
Monitoring records — INR, HbA1c, lithium levels, vancomycin troughs, opiate titration logs
Best Interests decision documentation if covert medication is in use
Adverse-reaction or near-miss records
Risk assessment for self-administration or refusal of medication
Pharmacy review letters and any medication reconciliation following hospital discharge

How ICBs commonly under-score this domain

Pattern: Assessor scored Moderate because medication is administered 'safely' by trained carers.

Rebuttal: Safe administration by trained carers is evidence of the SKILLED-staff requirement at the higher descriptor, not evidence that the underlying need is Moderate. Per the well-managed needs principle, the level must reflect what would happen if the trained-staff intervention were withdrawn.

Source: para 162-166

Pattern: Assessor scored High instead of Severe because syringe-driver doses are 'stable'.

Rebuttal: Severe descriptor explicitly contemplates daily monitoring and adjustment by skilled professionals. Syringe-driver use in itself meets Severe — it requires daily checks for line patency, drug compatibility, and breakthrough symptom assessment, regardless of whether titration is currently quiet.

Source: DST Annex C Drug Therapies Severe descriptor

Pattern: Assessor scored Severe instead of Priority where covert administration plus IV plus controlled drugs are all in concurrent use.

Rebuttal: Priority descriptor turns on need for the skills of a registered professional throughout 24 hours. Concurrent covert administration + IV + controlled drugs typically requires that skill set — particularly where titration is ongoing or breakthrough symptoms are unpredictable.

Source: DST Annex C Drug Therapies Priority descriptor

4-line rebuttal template

I disagree with the [LEVEL] score for Drug Therapies & Medication. The evidence shows [SPECIFIC PATTERN — syringe driver, IV, controlled drugs, covert, complex titration] which meets the [HIGHER LEVEL] descriptor. On [DATE/PERIOD], the regime included [DESCRIBE MEDICATIONS, FREQUENCY, ROUTE, MONITORING REQUIRED, SKILLED-STAFF INVOLVEMENT]. Per the well-managed needs principle (National Framework paras 162–166), the trained-carer administration is the intervention, not the absence of need. If skilled administration were withdrawn, the present-day risk would be [DESCRIBE: missed dose / titration error / line infection / breakthrough symptoms]. I therefore request the Drug Therapies & Medication domain be re-scored to [HIGHER LEVEL] with reference to the [SPECIFIC EVIDENCE: MAR chart / syringe-driver chart / specialist nurse notes / monitoring records].

Drug Therapies & Medication is one of four Priority-eligible domains

A single Priority score in Drug Therapies & Medication can secure CHC eligibility on this domain alone. The MDT Preparation Pack (£799) walks through exactly how to prepare your Drug Therapies & Medication evidence for the MDT.

View MDT Preparation Pack →